drugset / Trial / NCT02460146
PK and PD of Sequential Multiple Ascending, Repeat Doses of Oral CXA-10 in Healthy Obese Male Subjects
RandomizedSingle-groupQuadruple-blindTreatment
Summary
The main purpose of this trial is to demonstrate the safety, tolerability and pharmacokinetics (PK) of CXA-10 and its metabolite(s) administered as multiple ascending oral doses over 14 days to healthy obese male volunteers.
Timeline
- Start
- 2015-04
- Primary completion
- 2015-09
- Completion
- 2015-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | CXA-10 | Small molecule | — | Oral |